Status:
COMPLETED
Prevalence of Age Related Macular Degeneration (ARMD) in Parkinson's Patients and Assesment of the Role of L-DOPA
Lead Sponsor:
Fondation Ophtalmologique Adolphe de Rothschild
Conditions:
Parkinson Disease
Age Related Macular Degeneration
Eligibility:
All Genders
50+ years
Brief Summary
Age related macular degeneration (ARMD) is a major and irreversible cause of blindness among the elderly. The sub-retinal space, located between the retinal pigmentary epithelium (RPE) and the externa...
Eligibility Criteria
Inclusion
- Patients aged of 50 years old and more
- Parkinson's disease
Exclusion
- Patient under a measure of legal protection
Key Trial Info
Start Date :
January 19 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 15 2019
Estimated Enrollment :
133 Patients enrolled
Trial Details
Trial ID
NCT03415984
Start Date
January 19 2018
End Date
January 15 2019
Last Update
February 1 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondation ophtalmologique Adolphe de Rothschild
Paris, France, 75019